Opioids and Social Support Enhanced Extinction Effects
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Nov 14, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy adults 18 and 35
- • fluent in English
- • no history of mental illness (including anxiety, depression, phobia, or any other mental health related disorder diagnosed by a mental health professional)
- Exclusion Criteria:
- • pregnant or planning to become pregnant during the experiment period
- • presence of chronic mental illness (as determined by the report of a past diagnosis of mental illness by a physician or psychologist and/or the prescription of medication related to mental health disorder; including anxiety, depression, phobia, or any other diagnosed psychological disorder)
- • chronic physical illness (as determined by past diagnosis and/or treatment by a physician)
- • history of liver disease or abnormal liver function
- • current and regular use of prescription medications related to mental health disorders or liver function
- • previous history of fainting during blood draws
- • difficulty or discomfort swallowing pills
- • history of substance abuse or addiction (especially alcohol or opiate abuse)
- • Other exclusion criteria may apply.
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Naomi Eisenberger, Ph.D.
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials